First Quarter Financial Statement And Dividend Announcement FINANCIAL HIGHLIGHTS

Revenue

1st Qtr 2017

US$' 000

1st Qtr 2016

US$' 000

Change

%

2,046,446

1,493,603

37.0

Gross Profit

290,937

262,368

10.9

EBITDA1

182,780

141,875

28.8

Underlying profit 2

83,598

49,309

69.5

Underlying profit per share (USD cents)

0.66

0.39

69.5

Net Profit attributable to owners of the Company

37,552

94,091

(60.1)

Notes:

  1. Earnings before tax, non-controlling interests, interest on borrowings, depreciation and amortisation, net (loss)/gain from changes in fair value of biological assets and foreign exchange (loss)/gain.

  2. Net profit attributable to owners of the Company excluding net effect of net gain or loss from changes in fair value of biological assets and depreciation of bearer plants and other non-operating items (foreign exchange gain or loss, net tax impact from tax- based asset revaluations, and other deferred tax income or expense).

PART I - INFORMATION REQUIRED FOR QUARTERLY (Q1, Q2 & Q3), HALF-YEAR AND FULL YEAR ANNOUNCEMENTS

1(a) An income statement and statement of comprehensive income for the group together with a comparative statement for the corresponding period of the immediately preceding financial year

UNAUDITED CONSOLIDATED INCOME STATEMENT FOR THE PERIOD ENDED 31 MARCH 2017

1st Qtr 2017

US$' 000

1st Qtr 2016

US$' 000

Change

%

Revenue

2,046,446

1,493,603

37.0

Cost of sales

(1,755,509)

(1,231,235)

42.6

Gross profit

290,937

262,368

10.9

Operating expenses

Selling expenses

(141,508)

(152,125)

(7.0)

General and administrative expenses

(73,366)

(69,778)

5.1

Total operating expenses

(214,874)

(221,903)

(3.2)

Operating profit

76,063

40,465

88.0

Other income/(expenses)

Financial income

6,684

5,890

13.5

Financial expenses

(35,469)

(32,184)

10.2

Share of results of associated companies, net of tax

580

(26)

n.m.

Share of results of joint ventures, net of tax

1,609

3,527

(54.4)

Foreign exchange (loss)/gain

(1,155)

51,883

n.m.

Other operating income

5,489

9,557

(42.6)

(22,262)

38,647

n.m.

Profit before tax

53,801

79,112

(32.0)

Tax

(15,545)

14,488

n.m.

Profit for the period

38,256

93,600

(59.1)

Attributable to:

Owners of the Company

37,552

94,091

(60.1)

Non-controlling interests

704

(491)

n.m.

38,256

93,600

(59.1)

Notes:

(1) n.m. - not meaningful.

UNAUDITED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME FOR THE PERIOD ENDED 31 MARCH 2017

1st Qtr 2017

US$' 000

1st Qtr 2016

US$' 000

Profit for the period

38,256

93,600

Other comprehensive income/(loss):

Items that may be reclassified subsequently to profit or loss:

Foreign currency translation differences on consolidation

2,739

2,817

Share of other comprehensive income of a joint venture

453

1,055

Changes in fair value of cash flow hedges

(69)

742

Changes in fair value of available-for-sale financial assets

(9,574)

(1,653)

Other comprehensive (loss)/income, net of tax

(6,451)

2,961

Total comprehensive income for the period, net of tax

31,805

96,561

Total comprehensive income attributable to:

Owners of the Company

31,036

97,017

Non-controlling interests

769

(456)

31,805

96,561

ADDITIONAL INFORMATION Earnings before tax, non-controlling interests, interest on borrowings, depreciation and amortisation, net (loss)/gain from changes in fair value of biological assets and foreign exchange (loss)/gain ("EBITDA")

1st Qtr 2017

US$' 000

1st Qtr 2016

US$' 000

Change

%

Earnings before tax, non-controlling interests, interest on borrowings, depreciation and amortisation, net (loss)/gain from changes in fair value of biological assets and foreign exchange (loss)/gain ("EBITDA")

182,780

141,875

28.8

Interest on borrowings

(35,164)

(31,417)

11.9

Depreciation and amortisation

(91,773)

(85,395)

7.5

Net (loss)/gain from changes in fair value of biological assets

(887)

2,166

n.m.

Foreign exchange (loss)/gain

(1,155)

51,883

n.m.

Profit before tax

53,801

79,112

(32.0)

Notes:

(1) n.m. - not meaningful.

1(b)(i) A statement of financial position (for the issuer and group), together with a comparative statement as at the end of the immediately preceding financial year

UNAUDITED STATEMENTS OF FINANCIAL POSITION

Group

Company

As at

As at

As at

As at

31/3/2017 31/12/2016

31/3/2017

31/12/2016

US$' 000

US$' 000

US$' 000

US$' 000

Assets

Current Assets

Cash and cash equivalents

189,961

153,007

129

77

Short-term investments

203,683

201,972

-

-

Trade receivables

564,694

561,411

-

-

Other current assets (note (a))

929,177

892,529

54

19

Inventories

1,030,714

967,138

-

-

2,918,229

2,776,057

183

96

Non-Current Assets

Long-term receivables and assets (note (b))

258,922

253,008

-

-

Long-term investments

846,450

847,370

334,485

333,300

Subsidiary companies

-

-

2,038,893

2,040,149

Associated companies

10,744

10,158

-

-

Joint ventures

64,454

62,112

-

-

Investment properties

980

986

-

-

Property, plant and equipment

2,777,080

2,788,483

-

-

Bearer plants

1,063,136

1,101,374

-

-

Deferred tax assets

294,662

301,860

-

-

Intangible assets

165,890

165,007

-

-

5,482,318

5,530,358

2,373,378

2,373,449

Total Assets

8,400,547

8,306,415

2,373,561

2,373,545

gar - Golden Agri-Resources Ltd. published this content on 15 May 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 15 May 2017 09:42:16 UTC.

Original documenthttp://goldenagri.com.sg/wp-content/uploads/2017/05/GAR22-15-05-2017-Results1Q2017.pdf

Public permalinkhttp://www.publicnow.com/view/B5AAFA7703EF6FE167B08E619E5658A42155BC11